Literature DB >> 6652544

Pathophysiology and treatment of uremic bone disease.

J Coburn, J Kanis, M Popovtzer, E Ritz, E Slatopolsky, H Fleisch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6652544     DOI: 10.1007/BF02405110

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


× No keyword cloud information.
  7 in total

1.  Transplantation of the parathyroid glands in man: clinical indications and results.

Authors:  S A Wells; J C Gunnells; J D Shelburne; A B Schneider; L M Sherwood
Journal:  Surgery       Date:  1975-07       Impact factor: 3.982

2.  Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog.

Authors:  W E Rutherford; P Bordier; P Marie; K Hruska; H Harter; A Greenwalt; J Blondin; J Haddad; N Bricker; E Slatopolsky
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

3.  Study of intestinal absorption of calcium in patients with renal failure.

Authors:  J W Coburn; M H Koppel; A S Brickman; S G Massry
Journal:  Kidney Int       Date:  1973-04       Impact factor: 10.612

4.  Quantitative histological studies on the pathogenesis of uremic bone disease.

Authors:  D J Sherrard; D J Baylink; J E Wergedal; N A Maloney
Journal:  J Clin Endocrinol Metab       Date:  1974-07       Impact factor: 5.958

5.  How important is phosphate in the pathogenesis of renal osteodystrophy?

Authors:  E Slatopolsky; W E Rutherford; K Hruska; K Martin; S Klahr
Journal:  Arch Intern Med       Date:  1978-05-15

6.  Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium.

Authors:  M K Ward; T G Feest; H A Ellis; I S Parkinson; D N Kerr
Journal:  Lancet       Date:  1978-04-22       Impact factor: 79.321

7.  The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy.

Authors:  S M Ott; N A Maloney; J W Coburn; A C Alfrey; D J Sherrard
Journal:  N Engl J Med       Date:  1982-09-16       Impact factor: 91.245

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.